Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
5.7%
0.42
0.60
0.38
0.74%
-17.6%
93.22
Nifty 100 benchmark
14.4%
0.28
0.40
—
—
-37.0%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
36 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
2,479
-10.6%
8.0%
34.6%
6%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
How it behaves against its benchmark
Up capture
Down capture
Correlation
Tracking error
Information ratio
Treynor
52%
30%
0.97
9.0%
-0.20
6.04
Up capture is how much of the benchmark's gain this scheme kept in the months the
benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it
on the up side is the combination every fund is trying for and few reach.
Measured over the 36 months this scheme and
Nifty 100 share.
Axis Equity Savings Fund
Regular Plan · Growth Option
Allocation
By asset
Equity
68.21%
Debt
20.07%
Cash & Equivalents
5.89%
Mutual Fund Units
3.08%
REITs / InvITs
2.74%
By market cap
Large Cap
52.38%
Mid Cap
7.69%
Small Cap
7.99%
Unclassified
26.04%
Concentration
Number of stocks
110
Top 5 stocks
26.40%
Top 10 stocks
40.29%
Top 20 stocks
55.44%
Lines in the filing
170
Largest holding
6.88%
Largest sector
Banks 20.73%
Effective stocks
42.5
Sectors held
38
Cash
5.89%
Effective stocks is what the concentration works out to: a fund holding
110 names but most of its money in a few
behaves like a fund of 43. Cash includes repo and TREPS, which
every fund parks money in overnight.
Sector split
Banks
20.73%
Sovereign
9.13%
Petroleum Products
6.43%
Cash & Equivalents
5.89%
Pharmaceuticals & Biotechnology
4.89%
CRISIL AA-
4.16%
Ferrous Metals
3.98%
Unclassified
3.08%
Realty
2.94%
ICRA AA+
2.93%
Telecom - Services
2.89%
Automobiles
2.54%
Auto Components
2.47%
Healthcare Services
2.35%
IT - Software
2.29%
Transport Infrastructure
2.23%
Aerospace & Defense
2.01%
Finance
1.96%
Construction
1.88%
CRISIL AA+
1.76%
Axis Equity Savings Fund
Regular Plan · Growth Option · holdings
Top 30 holdings
#
Company
Sector
Shares held
Value ₹ cr
% of fund
1
Net Receivables / (Payables)
Unclassified
—
287
33.61%
2
ICICI Bank Limited
Banks
444,804
59
6.88%
3
Reliance Industries Limited
Petroleum Products
461,500
55
6.41%
4
HDFC Bank Limited
Banks
631,122
45
5.23%
5
7.18% Government of India (14/08/2033)
Sovereign
4,000,000
40
4.69%
6
Clearing Corporation of India Ltd
Unclassified
—
37
4.30%
7
Kotak Mahindra Bank Limited
Banks
654,247
27
3.19%
8
Axis Money Market Fund - Direct Plan - Growth Option
Unclassified
168,087
26
3.08%
9
Tata Steel Limited
Ferrous Metals
1,387,500
26
2.99%
10
Cholamandalam Investment and Finance Company Ltd (27/02/2029) (FRN)
9% Aditya Birla Digital Fashion Ventures Limited (20/07/2029)
CRISIL AA-
1,000
10
1.16%
24
7.53% Tamilnadu State Development Loans (28/01/2037)
Sovereign
1,000,000
10
1.14%
25
Embassy Office Parks REIT
Realty
224,166
10
1.14%
26
RBL Bank Limited
Banks
219,075
9
1.03%
27
Infosys Limited
IT - Software
86,500
9
1.01%
28
Knowledge Realty Trust
Realty
750,000
9
1.00%
29
Jindal Steel Limited
Ferrous Metals
74,750
8
0.99%
30
Bajaj Finance Limited
Finance
88,000
8
0.99%
Axis Equity Savings Fund
Regular Plan · Growth Option · where the money sits
What the manager did last month
Between the filings of 31 May 2026 and 31 Jul 2026.
A position grows because the manager bought or because the price rose; only the share count separates them.
Bought
Sold
New positions
Sold out of
Price move of holdings
₹35 cr
₹46 cr
5
8
+6.00%
Stock
Shares traded
Shares
Price
Value ₹ cr
New position
Kusumgar Limited
103,890
entered
—
6.1
Cube Highways Trust-InvIT Fund
328,890
entered
—
5.2
Torrent Pharmaceuticals Limited
8,415
entered
—
4.3
Berger Paints (I) Limited
42,764
entered
—
2.2
TVS Motor Company Limited
1,400
entered
—
0.6
Added to
Indus Infra Trust
840,336
+305.6%
+6.0%
11.1
ICICI Bank Limited
27,300
+6.5%
+14.3%
3.9
Metropolis Healthcare Limited
42,601
+3,045.1%
+4.9%
2.5
Mahindra & Mahindra Limited
7,000
+12.4%
+11.6%
2.4
Sansera Engineering Limited
6,568
+93.8%
+17.0%
2.2
Hindustan Aeronautics Limited
4,200
+13.1%
+8.0%
2.0
Titan Company Limited
4,000
+23.8%
+19.6%
2.0
Bajaj Finance Limited
15,000
+22.6%
+25.7%
1.7
Trimmed
HDFC Bank Limited
253,850
-32.5%
+0.5%
19.0
Tech Mahindra Limited
48,300
-69.3%
+11.3%
8.0
S.J.S. Enterprises Limited
16,843
-67.8%
+13.6%
4.0
Max Healthcare Institute Limited
23,609
-79.7%
+13.8%
2.6
UltraTech Cement Limited
1,788
-35.1%
+3.7%
2.1
Bharat Heavy Electricals Limited
49,000
-32.9%
-2.3%
2.0
Reliance Industries Limited
13,504
-2.3%
-1.0%
1.8
State Bank of India
15,000
-13.8%
+6.5%
1.5
Sold out of
SRF Limited
8,400
exited
—
2.3
JB Chemicals & Pharmaceuticals Limited
10,000
exited
—
2.2
Onesource Specialty Pharma Limited
7,113
exited
—
1.3
TeamLease Services Limited
7,791
exited
—
1.1
Multi Commodity Exchange of India Limited
1,875
exited
—
0.6
Neuland Laboratories Limited
245
exited
—
0.4
Dixon Technologies (India) Limited
250
exited
—
0.3
Samvardhana Motherson International Limited
12,300
exited
—
0.2
Not equity
Previous filing
This filing
Change
Cash, repo and TREPS
₹0 cr
₹0 cr
+₹0 cr
Debt: bills, CDs and commercial paper
₹186 cr
₹185 cr
−₹1 cr
The list above is stocks and fund units. Treasury bills, repo and money-market
lines roll over every month by design — they are not decisions, so they are totalled here rather
than listed as activity.
A ₹10,000 monthly SIP over five years
Invested
Value
Gain
XIRR
₹600,000
₹729,882
₹129,882
7.78%
XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has
been invested for a different length of time.
Not investment advice. InvestVerdict is not a SEBI-registered Investment
Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 31 Oct 2026.